The authors found grade 3–5 treatment-related AEs at 16.3% (the most common were diarrhoea, increased alanine aminotransferase, and colitis), discontinued treatment at 15.8%, immune-mediated AEs and infusion reactions at 36.9%, and 4 deaths (Luke et al. 2022). Here, GPT is linked to colitis.